HENDERSON MICHAEL THOMAS sold 22.6% of their position (20K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.00M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/24/2026ACC: 0001636282-26-000084
Director
Since Jun 2023
-20K
Net shares
Net seller
$2.00M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−20K
Price / share
$100.00
Trade value
$2M
% of position
22.6%
6/22/2026
88.61K→68.61K
Total
Net shares
−20K
Net value
-$2M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | S · Sale | −20K | $100.00 | $2M | 22.6% | 88.61K | 68.61K |
| Total | −20K | -$2M | ||||||
Derivative Transactions0
No derivative transactions reported